Search filters

List of works by Emanuela Boveri

A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis

scientific article published on 10 January 2008

A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Walde

scientific article published on 05 July 2019

Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry.

scientific article published in November 2010

Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations

scientific article published on 19 November 2007

Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network

scientific article published on 09 September 2019

Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria

scientific article published on 6 October 2017

Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome

scientific article published on 02 April 2019

Diagnosis and management of prefibrotic myelofibrosis

scientific article published on 22 June 2018

Familial Chronic Myeloproliferative Disorders: Clinical Phenotype and Evidence of Disease Anticipation

scientific article published on 12 November 2007

High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma

scientific article published on 03 August 2009

Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients.

scientific article published on 25 November 2010

JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders.

scientific article published in November 2006

Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination

scientific article published on 01 March 2006

Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.

scientific article published on 5 October 2017

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.

scientific article published on 11 September 2008

Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS

scientific article published on September 30, 2010

Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders.

scientific article

Ruxolitinib treatment and risk of B-cell lymphomas in myeloproliferative neoplasms

scientific article published on 01 May 2019

Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires.

scientific article published on 27 February 2009

Telangiectasia macularis eruptiva perstans: a neglected type of mastocytosis with exclusively cutaneous involvement? A case series

scientific article published on 01 April 2019

The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry

scientific article published on 12 September 2018

Validation of cytogenetic-based risk stratification in primary myelofibrosis.

scientific article published in April 2010